Onconetix
ONCO
5 hedge funds and large institutions have $2.7M invested in Onconetix in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
67% more funds holding
Funds holding: 3 → 5 (+2)
56% more capital invested
Capital invested by funds: $1.73M → $2.7M (+$967K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFG
American Financial Group
Cincinnati,
Ohio
|
+$348K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$174K |
| 3 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$174K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$12.6K |
| 2 |
JP Morgan Chase
New York
|
-$5K |
ONCO Hedge Fund Activity: Q2 2023 in Review
5 of the 6,382 institutional investors tracked by Wall St. Rank reported a position in Onconetix (ONCO) for Q2 2023, worth a combined $2.7M — up 56% from $1.73M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ONCO positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was American Financial Group, adding an estimated $348K. The largest seller was Two Sigma Securities, cutting an estimated $12.6K.
- 5 institutional investors held Onconetix (ONCO) as of Q2 2023, up from 3 in Q1 2023.
- Funds reported $2.7M of Onconetix stock for Q2 2023, up 56% quarter-over-quarter.
- 2 funds opened new Onconetix positions in Q2 2023 and 0 closed out, a net change of +2 holders.
- The largest Onconetix buyer in Q2 2023 was American Financial Group, an estimated $348K added.
- The largest Onconetix seller in Q2 2023 was Two Sigma Securities, an estimated $12.6K sold.
Based on aggregated 13F filings for Q2 2023.